Karl Werdan
Impact in
- Emergency Medicine top 0.1%
- Cardiac Arrest and Resuscitation
-
- Heart Failure Treatment and Management
- Heart Rate Variability and Autonomic Control
- Acute Myocardial Infarction Research
Papers in
-
- Heart Failure Treatment and Management 41
- Heart Rate Variability and Autonomic Control 38
- Cardiac electrophysiology and arrhythmias 34
-
- Intensive Care Unit Cognitive Disorders 26
- Co-authors
- Hans Walter HeldtUrsula Müller‐WerdanHenning EbeltMichael BuerkeHölger ThieleUwe ZeymerRoland ProndzinskyHarald Loppnow
- Journals
- Shock (17 papers)Clinical Research in Cardiology (15 papers)Critical Care Medicine (13 papers)Critical Care (12 papers)Biochemical Pharmacology (11 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Karl Werdan
443 papers receiving 12.7k citations
Hit Papers
Peers
Comparison fields: 5 of 170
- Emergency Medicine 2.6k
- Cardiology and Cardiovascular Medicine 4.7k
- Critical Care and Intensive Care Medicine 863
- Surgery 4.0k
- Biomedical Engineering 3.6k
Countries citing papers authored by Karl Werdan
This map shows the geographic impact of Karl Werdan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Werdan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Werdan more than expected).
Fields of papers citing papers by Karl Werdan
This network shows the impact of papers produced by Karl Werdan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Werdan. The network helps show where Karl Werdan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Karl Werdan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2022 | 11 | |
| 5 | 2022 | 5 | |
| 6 | 2018 | 16 | |
| 7 | 2016 | 7 | |
| 8 | 2016 | 41 | |
| 9 | 2015 | 11 | |
| 10 | 2010 | 2 | |
| 11 | 2010 | 25 | |
| 12 | 2008 | 26 | |
| 13 | A study of Platelet Activation by Bacterial Toxins | 2007 | 1 |
| 14 | 2006 | 36 | |
| 15 | 2004 | 134 | |
| 16 | 1997 | 11 | |
| 17 | Screening for prostatic carcinoma with prostate specific antigen. | 1997 | 3 |
| 18 | Cytokines and the heart : molecular mechanisms of septic cardiomyopathy | 1996 | 17 |
| 19 | 1993 | 0 | |
| 20 | 1993 | 1 |
About Karl Werdan
Karl Werdan is a scholar working on Cardiology and Cardiovascular Medicine, Critical Care and Intensive Care Medicine, Emergency Medicine, Internal Medicine and Epidemiology, having authored 471 papers that have together received 13.2k indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (87 papers), Mechanical Circulatory Support Devices (68 papers), Heart Failure Treatment and Management (41 papers), Cardiac Arrest and Resuscitation (41 papers), Heart Rate Variability and Autonomic Control (38 papers), Cardiac electrophysiology and arrhythmias (34 papers), Cardiac Structural Anomalies and Repair (33 papers) and Intensive Care Unit Cognitive Disorders (26 papers). The work is most often cited by research in Emergency Medicine (2.6k citations), Cardiology and Cardiovascular Medicine (4.7k citations), Critical Care and Intensive Care Medicine (863 citations), Surgery (4.0k citations) and Biomedical Engineering (3.6k citations). Karl Werdan has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Hans Walter Heldt, Ursula Müller‐Werdan, Henning Ebelt, Michael Buerke, Hölger Thiele, Uwe Zeymer, Roland Prondzinsky, Harald Loppnow, Steffen Desch and Ingo Eitel. Their work appears in journals such as Shock, Clinical Research in Cardiology, Critical Care Medicine, Critical Care and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.